PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Loewenstein Medical Technology S.a.

USPTO PatentsView assignee record - 77 granted patents across 24 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

Explore the portfolio See the ranking
77
Total patents granted
24
CPC technology areas
19.0
Avg claims per patent
+392%
5-year filing velocity

The verdict

Loewenstein holds 77 US patents across 24 technology areas, rank #4,567 of 50,000 tracked assignees.

#4,567
of 50,000 US assignees by volume
Top 4%
by Innovation Score (58.6/100)
19.0
avg claims per patent
+392%
filing velocity, last 5 yrs

Portfolio overview

Loewenstein Medical Technology S.a. has been granted 77 US utility patents between 2017 and 2025, placing Loewenstein Medical Technology S.a. at rank #4,567 across all assignees tracked by PlainPatent. This portfolio spans 24 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.0 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Loewenstein Medical Technology S.a. is one of the more focused assignees in the PatentsView dataset. By volume, Loewenstein sits between Idorsia Pharmaceuticals Ltd (77 patents, rank #4,563) and Mie Fujitsu Semiconductor Limited (77 patents, rank #4,571) - the closest US assignees by grant volume. The composite Innovation Score of 58.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 64 grants, compared with 13 in the 2015–2019 window, a +392% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Loewenstein Medical Technology S.a.'s 19.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 24 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Loewenstein Medical Technology S.a. against peers pursuing similar technology classes.

Who files at Loewenstein's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Loewenstein holds 77 patents at rank #4,567, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Loewenstein

By rank, the assignees closest to #4,567 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Loewenstein's primary technology class.

Loewenstein's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

59 Top 4% higher than 96% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 201720182019202020212022202320242025 12
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Loewenstein Medical Technology S.a. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 3 3.9%
2018 4 5.2%
2019 6 7.8%
2020 4 5.2%
2021 8 10.4%
2022 11 14.3%
2023 14 18.2%
2024 15 19.5%
2025 12 15.6%

Which technologies does Loewenstein Medical Technology S.a. patent most?

Top 15 of 24 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#4,567

Across all tracked assignees

Innovation Score

58.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Loewenstein Medical Technology S.a. hold?
Loewenstein Medical Technology S.a. holds 77 US granted patents filed between 2017 and 2025, spanning 24 technology areas.
What is Loewenstein Medical Technology S.a.'s Innovation Score?
Loewenstein Medical Technology S.a. has an Innovation Score of 58.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Loewenstein Medical Technology S.a. focus on?
Loewenstein Medical Technology S.a.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 73 patents. The company has filed patents in 24 CPC subclasses total.
Is Loewenstein Medical Technology S.a.'s patent filing rate increasing or decreasing?
Loewenstein Medical Technology S.a.'s recent filing velocity is +392% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Loewenstein Medical Technology S.a.'s patents?
Loewenstein Medical Technology S.a.'s patents average 19.0 claims each. This falls within the standard range, providing solid legal coverage.
How is the Loewenstein Medical Technology S.a. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Loewenstein's 77 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Loewenstein ranks #4,567 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.